Evidence map›Paper›PMID 36406217›Full record

ArticleFrontiers in bioengineering and biotechnology2022

Cyto- and bio-compatibility assessment of plasma-treated polyvinylidene fluoride scaffolds for cardiac tissue engineering.

Maria Kitsara, Gaëlle Revet, Jean-Sébastien Vartanian-Grimaldi, Alexandre Simon, Mathilde Minguy, Antoine Miche, Vincent Humblot, Thierry Dufour, Onnik Agbulut

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Plasma activated PVDF-BaTiOScientific reports · 2025
    Article
  4. Engineering Nanoparticles and Bioscaffolds for Targeted microRNA Delivery in Cardiovascular Regeneration-A Comprehensive Review.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  5. Article
  6. The application of impantable sensors in the musculoskeletal system: a review.Frontiers in bioengineering and biotechnology · 2024
    Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Maria KitsaraUMR CNRS 8256, INSERM ERL 1164, Biological Adaptation and Ageing, Institut de Biologie Paris-Seine, Sorbonne Université, Paris, France.
Gaëlle RevetUMR CNRS 8256, INSERM ERL 1164, Biological Adaptation and Ageing, Institut de Biologie Paris-Seine, Sorbonne Université, Paris, France.
Jean-Sébastien Vartanian-GrimaldiUMR CNRS 8256, INSERM ERL 1164, Biological Adaptation and Ageing, Institut de Biologie Paris-Seine, Sorbonne Université, Paris, France.
Alexandre SimonUMR CNRS 8256, INSERM ERL 1164, Biological Adaptation and Ageing, Institut de Biologie Paris-Seine, Sorbonne Université, Paris, France.
Mathilde MinguyUMR CNRS 8256, INSERM ERL 1164, Biological Adaptation and Ageing, Institut de Biologie Paris-Seine, Sorbonne Université, Paris, France.
Antoine MicheUMR CNRS 7197, Laboratoire de Réactivité de Surface, Sorbonne Université, Paris, France.
Vincent HumblotUMR CNRS 7197, Laboratoire de Réactivité de Surface, Sorbonne Université, Paris, France.
Thierry DufourUMR CNRS 7648, Laboratoire de Physique des Plasmas, Sorbonne Université, Paris, France.
Onnik AgbulutUMR CNRS 8256, INSERM ERL 1164, Biological Adaptation and Ageing, Institut de Biologie Paris-Seine, Sorbonne Université, Paris, France.
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As part of applications dealing with cardiovascular tissue engineering, drop-cast polyvinylidene fluoride (PVDF) scaffolds have been treated by cold plasma to enhance their adherence to cardiac cells. The scaffolds were treated in a dielectric barrier device where cold plasma was generated in a gaseous environment combining a carrier gas (helium or argon) with/without a reactive gas (molecular nitrogen). We show that an Ar-N

Indexed as

biocompatibilitycardiac tissue engineeringplasma treatmentpolyvinylidene fluoridescaffoldssurface functionalization

Identifiers

PMID36406217
PMCPMC9672675
OpenAlexW4308334504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.